Acta medica portuguesa · 2018
[Polysaccharide of Escherichia coli in the Prevention of Recurrent Urinary Tract Infection: An Evidence-Based Review].
СтатьяСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tinoco Manuel, Santos Mélody, Reitor Conceição, Rodrigues Andreia, Monteiro João
Аннотация
INTRODUCTION: Recurrent urinary tract infection is frequent and it is related to morbidity, costs and growing antibiotic resistance. OM 8930 vaccine is composed by Escherichia coli polysaccharide and it is a possible prophylactic measure, but there is doubt as to its effectiveness.
MATERIAL AND METHODS: We performed a systematic review in evidence-based medicine databases with rigorous bibliography selection.
RESULTS: We found an effective decrease of recurrences in test groups.
DISCUSSION: We recommend the administration of the vaccine as prophylaxis of recurrent cystitis.
CONCLUSION: The vaccine has impact on the recurrent cystitis relapse rate. We suggest that more studies be carried out to evaluate the vaccine cost-benefit and its effectiveness in complicated urinary infections.
MATERIAL AND METHODS: We performed a systematic review in evidence-based medicine databases with rigorous bibliography selection.
RESULTS: We found an effective decrease of recurrences in test groups.
DISCUSSION: We recommend the administration of the vaccine as prophylaxis of recurrent cystitis.
CONCLUSION: The vaccine has impact on the recurrent cystitis relapse rate. We suggest that more studies be carried out to evaluate the vaccine cost-benefit and its effectiveness in complicated urinary infections.